Table 3 The relationships between microRNA-143 expression and clinical features of patients in the restenosis and non-restenosis groups
Feature | Restenosis group (n = 74) | Non-restenosis group (n = 91) | ||||||
|---|---|---|---|---|---|---|---|---|
N | Relative expression | t | P | N | Relative expression | t | P | |
Age (years) | ||||||||
<60 | 40 | 0.53 ± 0.07 | 1.39 | 0.169 | 49 | 0.64 ± 0.14 | 0.64 | 0.526 |
≥60 | 34 | 0.51 ± 0.05 | 42 | 0.62 ± 0.16 | ||||
Smoking | ||||||||
Yes | 59 | 0.50 ± 0.04 | 7.75 | <0.001 | 27 | 0.62 ± 0.14 | 0.28 | 0.779 |
No | 15 | 0.60 ± 0.06 | 64 | 0.63 ± 0.16 | ||||
Diabetes | ||||||||
Yes | 21 | 0.48 ± 0.04 | 3.51 | 0.001 | 6 | 0.62 ± 0.20 | 0.16 | 0.878 |
No | 53 | 0.53 ± 0.06 | 85 | 0.63 ± 0.15 | ||||
Blood sugar | ||||||||
High | 14 | 0.45 ± 0.04 | 6.27 | <0.001 | 19 | 0.60 ± 0.12 | 1.11 | 0.313 |
Low | 60 | 0.54 ± 0.05 | 72 | 0.64 ± 0.16 | ||||
LDL-C | ||||||||
>2.6 mmol/L | 35 | 0.49 ± 0.06 | 5.11 | <0.001 | 20 | 0.61 ± 0.12 | 0.78 | 0.439 |
≤2.6 mmol/L | 39 | 0.55 ± 0.04 | 71 | 0.64 ± 0.1 | ||||
Hyperlipidemia | ||||||||
Yes | 15 | 0.51 ± 0.04 | 0.61 | 0.544 | 17 | 0.64 ± 0.15 | 0.74 | 0.459 |
No | 59 | 0.52 ± 0.06 | 74 | 0.63 ± 015 | ||||